NAFLD is associated with an increase in components of the renin–angiotensin system, such as angiotensin II, that can contribute to vascular damage via increases in oxidative stress and subsequently blocking the insulin-signaling pathways and accelerating atherosclerosis [89]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.